Depomed reported $7.98M in EBIT for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Aerie Pharmaceuticals AERI:US $ -33643000 85.38M
Ani Pharmaceuticals ANIP:US $ -19195000 1.8M
Aurora Cannabis Inc ACB:CN C$ -110537000 13M
Cara Therapeutics CARA:US $ -27911000 5.61M
Daiichi Sankyo 4568:JP -50747000000 89.78B
Ironwood Pharmaceuticals IRWD:US $ 57.85M 1.25M
Johnson & Johnson JNJ:US $ 7540M 1623M
Knight Therapeutics Inc GUD:CN C$ -316000 12.72M
Merk MRK:US $ 5059M 207M
Nektar Therapeutics NKTR:US $ -115085000 2.17M
Omeros OMER:US $ -35046000 65.69M
Pfizer PFE:US $ 9995M 4136M
Teva Pharmaceutical TEVA:IT 789M 182M